(Q43620879)

25 November 2017

title

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial (English)

1 reference

multicenter clinical trial

25 November 2017

main subject

1 reference

1 reference

1 reference

1 reference

V Georgoulias

1

1 reference

25 November 2017

E Papadakis

2

1 reference

25 November 2017

A Alexopoulos

3

1 reference

25 November 2017

X Tsiafaki

4

1 reference

25 November 2017

A Rapti

5

1 reference

25 November 2017

M Veslemes

6

1 reference

25 November 2017

P Palamidas

7

1 reference

25 November 2017

I Vlachonikolis

8

1 reference

25 November 2017

Greek Oncology Cooperative Group (GOCG) for Lung Cancer

9

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

357

1 reference

25 November 2017

issue

9267

1 reference

25 November 2017

page(s)

1478-1484

1 reference

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: A multicenter phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

A Randomized Trial with Mitomycin-C/Ifosfamide Versus Mitomycin-C/Vindesine Versus Cisplatin/Etoposide in Advanced Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904644-4

7 January 2021

10.1016/S0140-6736(00)04644-4

Identifiers

DOI

1 reference

25 November 2017

1 reference